Relay Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €86.71M +647.8% -€273.83M -12.8% -315.8% +24 pp N/A N/A
    (estimated) €11.60M -56.6% -€314.09M +8.6% -2,708.5% -16 pp N/A N/A
    (estimated) €26.73M +208.4% -€289.11M +12.4% -1,081.4% +19 pp N/A N/A
    (estimated) €8.67M -22.1% -€257.16M +6.8% -2,967.0% -8.0 pp N/A N/A
    (estimated) €11.13M +29.1% -€240.81M -17.2% -2,163.4% +12 pp N/A N/A
    €8.62M -60.8% -€290.95M -1.2% -3,374.7% -20 pp -€212.88M -16.6% -2,469.2% -13 pp
    €22.01M +1,749.8% -€294.63M +34.5% -1,338.7% +170 pp -€255.18M +34.4% -1,159.4% +150 pp
    €1.19M -54.4% -€219.06M -48.8% -18,411.2% -20 pp -€189.91M +210.7% -15,961.5% -140 pp
    €2.61M -96.3% -€428.02M +913.6% -16,401.7% -160 pp -€61.11M -29.5% -2,341.9% -22 pp
    €71.21M +∞% -€42.23M -26.3% -59.3% -0.59 pp -€86.64M +73.0% -121.7% -1.2 pp
    €0.00 +NaN% -€57.30M +36.3% N/A -€50.08M +36.9% N/A
    €0.00 -€42.03M N/A -€36.57M N/A

    Notifications